目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value
3.2. Market volume

4 Market Segmentation
4.1. Geography segmentation

5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What are the strengths of the leading players?
7.4. What are the most recent generic drugs launched in the market?

8 Company Profiles
8.1. Teva Pharmaceutical Industries Ltd
8.2. Viatris Inc
8.3. Pfizer Inc
8.4. Sandoz Inc

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: United States generics market value: $ million, 2018-23
Table 2: United States generics market volume: % of total pharma volume, 2018-23
Table 3: United States generics market geography segmentation: $ million, 2023
Table 4: United States generics market value forecast: $ million, 2023-28
Table 5: United States generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Teva Pharmaceutical Industries Ltd: Key Facts
Table 7: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Ltd: Key Employees
Table 9: Viatris Inc: Key Facts
Table 10: Viatris Inc: Annual Financial Ratios
Table 11: Viatris Inc: Key Employees
Table 12: Pfizer Inc: Key Facts
Table 13: Pfizer Inc: Annual Financial Ratios
Table 14: Pfizer Inc: Key Employees
Table 15: Sandoz Inc: Key Facts
Table 16: Sandoz Inc: Key Employees
Table 17: United States Size of Population (million), 2019-23
Table 18: United States Real GDP (Constant 2010 Prices, $ Billion), 2019-23
Table 19: United States GDP (Current Prices, $ Billion), 2019-23
Table 20: United States Inflation, 2019-23
Table 21: United States Consumer Price Index (Absolute), 2019-23
Table 22: United States Exchange Rate, 2018-23

List of Figures
Figure 1: United States generics market value: $ million, 2018-23
Figure 2: United States generics market volume: % of total pharma volume, 2018-23
Figure 3: United States generics market geography segmentation: % share, by value, 2023
Figure 4: United States generics market value forecast: $ million, 2023-28
Figure 5: United States generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the generics market in the United States, 2023
Figure 7: Drivers of buyer power in the generics market in the United States, 2023
Figure 8: Drivers of supplier power in the generics market in the United States, 2023
Figure 9: Factors influencing the likelihood of new entrants in the generics market in the United States, 2023
Figure 10: Factors influencing the threat of substitutes in the generics market in the United States, 2023
Figure 11: Drivers of degree of rivalry in the generics market in the United States, 2023